<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04797416</url>
  </required_header>
  <id_info>
    <org_study_id>2020477</org_study_id>
    <nct_id>NCT04797416</nct_id>
  </id_info>
  <brief_title>The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time</brief_title>
  <official_title>The Evaluation of Consistency by Finger Stick Blood Glucose or Venous Blood Glucose of Flash Glucose Monitoring in Different Infiltration Time</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective randomized controlled study to evaluate consistency by finger stick&#xD;
      blood glucose or venous blood glucose in different infiltration time (including the time&#xD;
      between activation of the sensor and storage of the first blood glucose value) of Flash&#xD;
      glucose monitoring(FGM). In this study, the relationship between the dynamic blood glucose&#xD;
      and finger stick blood glucose or venous blood glucose in type 2 diabetes mellitus&#xD;
      patients(T2DM), was explored. And the investigators also analyzed the deviation and accuracy&#xD;
      of FGM in practical application,so as to provide a good reference for clinical application.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Difference value</measure>
    <time_frame>Up to 21 days</time_frame>
    <description>The difference between finger stick blood glucose or venous blood glucose and FGM value.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">480</enrollment>
  <condition>Type 2 Diabetes</condition>
  <condition>Flash Glucose Monitoring</condition>
  <condition>Conscience</condition>
  <arm_group>
    <arm_group_label>1-hour group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The time between the activation of the sensor and the storage of the first blood glucose value is 1 hour.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>6-hour group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The time between the activation of the sensor and the storage of the first blood glucose value is 6 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>12-hour group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The time between the activation of the sensor and the storage of the first blood glucose value is 12 hours.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FGM infiltration 1 hour group</intervention_name>
    <description>The sensor is activated immediately after wearing (including the time between the sensor activation and the first blood glucose value stored，about 1 hour).</description>
    <arm_group_label>1-hour group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FGM infiltration 6-hour group</intervention_name>
    <description>Reactivate the sensor 5 hours after wearing (including the time between the sensor activation and the first blood glucose value stored，about 1 hour).</description>
    <arm_group_label>6-hour group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FGM infiltration 12-hour group</intervention_name>
    <description>Reactivate the sensor 11 hours after wearing (including the time between the sensor activation and the first blood glucose value stored，about 1 hour).</description>
    <arm_group_label>12-hour group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with type 2 diabetes fit the 1999 who diagnostic criteria for diabetes&#xD;
&#xD;
          -  Aged 18 or above&#xD;
&#xD;
          -  Without serious complications, such as diabetic ketoacidosis, severe infection,severe&#xD;
             cardiac insufficiency, severe liver and kidney diseases&#xD;
&#xD;
          -  Voluntary and signed informed consent to participate&#xD;
&#xD;
          -  Be able to read and understand Chinese, perform all research visits and tasks, and&#xD;
             follow research instructions&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with known allergy to medical grade adhesive or isopropanol used for skin&#xD;
             disinfection, edema, skin damage, scar, redness, infection, etc. during pregnancy or&#xD;
             preparation of pregnancy or at the sensor application site (dorsal side of upper arm).&#xD;
&#xD;
          -  The examinee took drugs such as ascorbic acid (vitamin C) and salicylic acid (an&#xD;
             ingredient in aspirin and many painkillers) that affected the accuracy of the sensor.&#xD;
&#xD;
          -  MRI is required during the study.&#xD;
&#xD;
          -  The examinee had poor compliance and could not continue to complete the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>endocrinology department of the first affiliated hospital of Sun Yat-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 4, 2021</study_first_submitted>
  <study_first_submitted_qc>March 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 15, 2021</study_first_posted>
  <last_update_submitted>March 11, 2021</last_update_submitted>
  <last_update_submitted_qc>March 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yanbing Li</investigator_full_name>
    <investigator_title>Professer</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

